M

Mediphage Bioceuticals Inc.

21 employees

Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
plasmids for AAV manufacturing
gene therapy
Retina
CNS
biotechnology
Hemophilia
Medical
DNA Vaccine
gene editing
non-viral vectors

Date founded

2016

Funding rounds raised

Total raised

$3.5M

from 2 investors over 2 rounds

M

Mediphage Bioceuticals Inc. raised $3.5M on March 1, 2019

Investors: Viking Global Investors

M

Mediphage Bioceuticals Inc. raised $646K on March 1, 2018

Investors: Creative Destruction Lab

FAQ